"Non alcoholic fatty liver disease and eNOS dysfunction in humans".
Marcello PersicoMario MasaroneAntonio DamatoMariateresa AmbrosioAlessandro FedericoValerio RosatoTommaso BucciAlbino CarrizzoCarmine VecchionePublished in: BMC gastroenterology (2017)
Our data showed, for the first time in humans, that NAFLD patients show a marked eNOS dysfunction, which may contribute to a higher CV risk. eNOS dysfunction observed in platelets and liver tissue didn't match with FMD.